Global Smart Insulin Pen Market By Product (Second Generation Pens,-Bluetooth-Enabled, USB Connected; First Generation), Usability (Reusable, Prefilled), End User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings) and Regional Forecasts 2021-2027

  • Product Code:
    RP-ID-10347681
  • Published Date:
    5 Sep 2021
  • Region:
    Global
  • Pages:
    200
  • Category:
    FMCG & Food
  • Publisher:
    Pub-ID-14

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

ccs

Market Overview:

Global Smart Insulin Pens s valued approximately USD 89.53 million in 2020and is anticipated to grow with a healthy growth rate of more than 10.77% over the forecast period 2021-2027.Diabetes is a major health problem that is rapidly increasing in the global population; therefore, the use of good internal secretion pens is significantfor the safe and effective administration of internal secretion to individuals suffering from polygenic disorder. Internal secretion pens are used to deliver internal secretion outwardly, provides higher polygenic diabetes management system. The increase in polygenic disorder cases boost the market growth. One of the key factors working in favour of the global market is the growing number of diabetics as a result of obesity, inactive lifestyles, and ageing. Fatness has emerged as one of the leading causes of polygenic disorder in people. Undernutrition are the first links to polygenic disorder cases, which are increasing at epidemic proportions. As a result of the large number of people affected by polygenic disorder, the market for sensible internal secretion pens is expanding globally.Smart insulin pens support in calculating personalized doses, continuously tracking glucose, and connecting with smartphone apps to visualize data. Moreover, Novo Nordisk and Abbott collaborated in 2019 to integrate insulin dose data into digital health tools, with the goal of connecting key technologies such as continuous glucose monitoring and insulin pen market size worldwide.Strict government regulations and high cost are the restraining factors of the market.

 

North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa make up the global smart insulin pens industry. North America is the industry leader for smart insulin pens, accounting for more than half of overall sales in 2017. Furthermore, North America generates the most sales due to the involvement of major players and a high rate of adoption of technologically advanced products. Furthermore, Asia Pacific is expected to expand rapidly over the forecast period. This is due to a rise in the number of geriatrics with diabetes, which is fueling the growth of the smart insulin pens market in this area.

Major market player included in this report are:
Companion Medical Inc.
Digital Medics Ptd Ltd.
Eli Lilly and Company
Novo Nordisk A/S
Diamesco Co., Ltd.
F. Hoffmann-La Roche AG
Insulet Corporation
Emperra GmbH E-Health Technologies
Jiangsu Delfu medical device Co. Ltd.
Bigfoot biomedica.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:
By Product
Second Generation Pens
USB Connected Smart Insulin Pen
Bluetooth-Enabled Smart Insulin Pen
First Generation Pens

By Usability
Prefilled
Reusable

By End User
Hospitals & Clinics
Ambulatory Surgical Centers
Home care settings
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027
Target Audience of the Smart Insulin Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


Geography Analysis:


The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook

.

FREQUENTLY ASKED QUESTIONS

Chapter 1.Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Million)
1.2.1. Smart Insulin Pen Market, by Region, 2019-2027 (USD Million)
1.2.2. Smart Insulin Pen Market, by Product,2019-2027 (USD Million)
1.2.3. Smart Insulin Pen Market, by Usability,2019-2027 (USD Million)
1.2.4. Smart Insulin Pen Market, by End-user,2019-2027 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Smart Insulin Pen Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Smart Insulin Pen Market Dynamics
3.1. Smart Insulin Pen Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increase in Polygenic Disorder
3.1.1.2. Future go far Beyond Memory Storage
3.1.2. Market Challenges
3.1.2.1. Strict Product Approval Process
3.1.2.2. High Manufacturing Costing
3.1.3. Market Opportunities
3.1.3.1. Establishing Online Distribution Channels
Chapter 4. Global Smart Insulin Pen MarketIndustry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Smart Insulin Pen Market, by Product
5.1. Market Snapshot
5.2. Global Smart Insulin Pen Market by Product, Performance - Potential Analysis
5.3. Global Smart Insulin Pen Market Estimates & Forecasts by Product2018-2027 (USD Million)
5.4. Smart Insulin Pen Market, Sub Segment Analysis
5.4.1. Second Generation pens
5.4.2. USB Connected Smart Insulin pens
5.4.3. Bluetooth-Enabled Smart Insulin pens
5.4.4. First Generation pens
Chapter 6. Global Smart Insulin Pen Market, byUsability
6.1. Market Snapshot
6.2. Global Smart Insulin Pen Market by Usability, Performance - Potential Analysis
6.3. Global Smart Insulin Pen Market Estimates & Forecasts by Usability2018-2027 (USD Million)
6.4. Smart Insulin Pen Market, Sub Segment Analysis
6.4.1. Pre-Filled Smart Insulin Pen
6.4.2. Reusable Owned Smart Insulin Pen
Chapter 7. Global Smart Insulin Pen Market, by End-user
7.1. Market Snapshot
7.2. Global Smart Insulin Pen Market by End-user, Performance - Potential Analysis
7.3. Global Smart Insulin Pen Market Estimates & Forecasts by End-user 2018-2027 (USD Million)
7.4. Smart Insulin Pen Market, Sub Segment Analysis
7.4.1. Hospitals and clinic
7.4.2. Ambulatory surgical centers
7.4.3. Home care settings

Chapter 8. Global Smart Insulin Pen Market, Regional Analysis
8.1. Smart Insulin Pen Market, Regional Market Snapshot
8.2. North America Smart Insulin Pen Market
8.2.1. U.S. Smart Insulin Pen Market
8.2.1.1. Productbreakdown estimates & forecasts, 2018-2027
8.2.1.2. Usabilitybreakdown estimates & forecasts, 2018-2027
8.2.1.3. End-userbreakdown estimates & forecasts, 2018-2027
8.2.2. Canada Smart Insulin Pen Market
8.3. Europe Smart Insulin Pen Market Snapshot
8.3.1. U.K. Smart Insulin Pen Market
8.3.2. Germany Smart Insulin Pen Market
8.3.3. France Smart Insulin Pen Market
8.3.4. Spain Smart Insulin Pen Market
8.3.5. Italy Smart Insulin Pen Market
8.3.6. Rest of Europe Smart Insulin Pen Market
8.4. Asia-Pacific Smart Insulin Pen Market Snapshot
8.4.1. China Smart Insulin Pen Market
8.4.2. India Smart Insulin Pen Market
8.4.3. Japan Smart Insulin Pen Market
8.4.4. Australia Smart Insulin Pen Market
8.4.5. South Korea Smart Insulin Pen Market
8.4.6. Rest of Asia Pacific Smart Insulin Pen Market
8.5. Latin America Smart Insulin Pen Market Snapshot
8.5.1. Brazil Smart Insulin Pen Market
8.5.2. Mexico Smart Insulin Pen Market
8.6. Rest of The World Smart Insulin Pen Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Companion Medical Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Digital Medics Ptd Ltd.
9.2.3. Eli Lilly and Company
9.2.4. Novo Nordisk A/S
9.2.5. Diamesco Co., Ltd.
9.2.6. F. Hoffmanna-La Roche AG
9.2.7. Insulet Corporation
9.2.8. Emperra GmbH E-Health Technologies
9.2.9. Jiangsu Delfu Medical Device Co. Ltd.
9.2.10. Bigfoot Biomedica
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Companion Medical Inc.
Digital Medics Ptd Ltd.
Eli Lilly and Company
Novo Nordisk A/S
Diamesco Co., Ltd.
F. Hoffmann-La Roche AG
Insulet Corporation
Emperra GmbH E-Health Technologies
Jiangsu Delfu medical device Co. Ltd.
Bigfoot biomedica.

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports